Key Takeaways
- U.S. stock indexes showed resilience despite a government shutdown, boosted by pharma rally and AI enthusiasm.
- Electronic Arts announced a record-setting $55 billion leveraged buyout, taking the company private.
- Pharmaceutical stocks surged following President Trump's 'Trump RX' initiative for discounted medicines.
- Fair Isaac's new direct-to-lender program for FICO scores disrupted credit bureaus, boosting FICO shares.
Deep Dive
- Electronic Arts announced a $55 billion leveraged buyout, marking the largest such deal in history to take the video game maker private.
- Known for titles like The Sims and Madden NFL, Electronic Arts entered into an agreement with a group of investors.
- This deal surpasses the previous record, the 2007 acquisition of TXU, which was approximately $32 billion.
- A rally in pharmaceutical stocks was sparked by President Trump's announcement of 'Trump RX,' a government-run website for discounted medicines.
- Pfizer plans to offer drugs on the site and introduce new ones at reduced prices, and in return, would receive a three-year exemption from national security tariffs for investing in domestic manufacturing.
- Pfizer shares surged 6.8% on Tuesday, leading S&P 500 gainers, and increased 15% for the week.
- Fair Isaac, the company behind FICO credit scores, announced a new program allowing mortgage lenders to offer its scores without purchasing them from major credit bureaus.
- This change enables resellers to obtain scores directly from FICO, bypassing traditional middlemen like Experian, Equifax, and TransUnion.
- Fair Isaac's stock (FICO) surged 18% on Thursday, while shares of TransUnion fell 11%, Equifax dropped 8.5%, and Experian declined nearly 5%.